Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001122955.4(BSCL2):c.1031C>T(p.Ser344Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,614,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
BSCL2 (HGNC:15832): (BSCL2 lipid droplet biogenesis associated, seipin) This gene encodes the multi-pass transmembrane protein protein seipin. This protein localizes to the endoplasmic reticulum and may be important for lipid droplet morphology. Mutations in this gene have been associated with congenital generalized lipodystrophy type 2 or Berardinelli-Seip syndrome, a rare autosomal recessive disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Naturally occurring read-through transcription occurs between this locus and the neighboring locus HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U-like 2).[provided by RefSeq, Mar 2011]
Uncertain significance, criteria provided, single submitter
clinical testing
Genetic Services Laboratory, University of Chicago
Aug 06, 2015
- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter
clinical testing
Ambry Genetics
Jan 07, 2022
The p.S280F variant (also known as c.839C>T), located in coding exon 7 of the BSCL2 gene, results from a C to T substitution at nucleotide position 839. The serine at codon 280 is replaced by phenylalanine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Severe neurodegenerative syndrome with lipodystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter
clinical testing
New York Genome Center
Nov 10, 2020
The p.Ser344Phe variant has not been reported in affected individuals in the literature. The variant has 0.0001 allele frequency in the gnomAD database (29 out of 282,872 heterozygous alleles) indicating it is a rare allele in the general population. The affected residue is moderately conserved and different in silico tools show conflicting predictions about the potential pathogenicity of this variant. -
Monogenic diabetes Uncertain:1
Uncertain significance, criteria provided, single submitter
research
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Uncertain significance, criteria provided, single submitter
clinical testing
GeneDx
Dec 19, 2022
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Charcot-Marie-Tooth disease type 2 Benign:1
Likely benign, criteria provided, single submitter
clinical testing
Labcorp Genetics (formerly Invitae), Labcorp
Nov 15, 2022
- -
Congenital generalized lipodystrophy type 2 Other:1
Uncertain risk allele, criteria provided, single submitter
research
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
-
Potent mutations in BSCL2 gene are associated with Congenital generalized lipodystrophy, type 2, which can present with insulin resistance, fatty liver and diabetes.However, the role of this particular variant rs140676897 of Congenital Generalized Lipodystrophy type 2 remains uncertain -